| Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma A Schaefer, M Jung, HJ Mollenkopf, I Wagner, C Stephan, F Jentzmik, ... International journal of cancer 126 (5), 1166-1176, 2010 | 754 | 2010 |
| Robust microRNA stability in degraded RNA preparations from human tissue and cell samples M Jung, A Schaefer, I Steiner, C Kempkensteffen, C Stephan, ... Clinical chemistry 56 (6), 998-1006, 2010 | 357 | 2010 |
| COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety A Fendler, EGE de Vries, CH GeurtsvanKessel, JB Haanen, B Wörmann, ... Nature Reviews Clinical Oncology 19 (6), 385-401, 2022 | 169 | 2022 |
| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 165 | 2021 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 161 | 2021 |
| Suitable reference genes for relative quantification of miRNA expression in prostate cancer A Schaefer, M Jung, K Miller, M Lein, G Kristiansen, A Erbersdobler, ... Experimental & molecular medicine 42 (11), 749-758, 2010 | 142 | 2010 |
| Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients A Fendler, D Bauer, J Busch, K Jung, A Wulf-Goldenberg, S Kunz, K Song, ... Nature Communications 11 (1), 929, 2020 | 138 | 2020 |
| MicroRNAs as regulators of signal transduction in urological tumors A Fendler, C Stephan, GM Yousef, K Jung Clinical chemistry 57 (7), 954-968, 2011 | 133 | 2011 |
| Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors A Schaefer, C Stephan, J Busch, GM Yousef, K Jung Nature Reviews Urology 7 (5), 286-297, 2010 | 128 | 2010 |
| The translational potential of microRNAs as biofluid markers of urological tumours A Fendler, C Stephan, GM Yousef, G Kristiansen, K Jung Nature Reviews Urology 13 (12), 734-752, 2016 | 126 | 2016 |
| MicroRNAs and cancer: current state and future perspectives in urologic oncology A Schaefer, M Jung, G Kristiansen, M Lein, M Schrader, K Miller, ... Urologic Oncology: Seminars and Original Investigations 28 (1), 4-13, 2010 | 123 | 2010 |
| Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases Z Wotschofsky, HA Meyer, M Jung, A Fendler, I Wagner, C Stephan, ... Analytical biochemistry 417 (2), 233-241, 2011 | 118 | 2011 |
| Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas J Busch, B Ralla, M Jung, Z Wotschofsky, E Trujillo-Arribas, P Schwabe, ... Journal of experimental & clinical cancer research 34, 1-11, 2015 | 107 | 2015 |
| MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis JP Patron, A Fendler, M Bild, U Jung, H Müller, MØ Arntzen, C Piso, ... PLoS One 7 (4), e35345, 2012 | 107 | 2012 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 90 | 2023 |
| Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 L Au, A Fendler, STC Shepherd, K Rzeniewicz, M Cerrone, F Byrne, ... Nature medicine 27 (8), 1362-1366, 2021 | 84 | 2021 |
| The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1 A Fendler, M Jung, C Stephan, A Erbersdobler, K Jung, GM Yousef PloS one 8 (11), e80807, 2013 | 82 | 2013 |
| miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression A Fendler, M Jung, C Stephan, RJ Honey, RJ Stewart, KT Pace, ... International journal of oncology 39 (5), 1183-1192, 2011 | 79 | 2011 |
| Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ... The Lancet 399 (10328), 905-907, 2022 | 77 | 2022 |
| Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients H Lu, J Busch, M Jung, S Rabenhorst, B Ralla, E Kilic, S Mergemeier, ... Clinica Chimica Acta 452, 109-119, 2016 | 69 | 2016 |
